Ayala Pharmaceuticals, Inc.: auditor change — Ayala Pharmaceuticals dismisses Marcum as auditor, engages KFGK for FY 2023

Ayala Pharmaceuticals, Inc.

Audit committee discontinued Marcum engagement on April 5, 2023; no disagreements with Marcum.
Marcum's audit reports for FY ended Oct 2022 and 2021 included a going concern explanatory paragraph.
KFGK (Kost, Forer, Gabbay & Kasierer, member of EY Global) engaged to audit FY ending Dec 31, 2023.
Change follows reverse merger where Old Ayala is accounting acquirer; KFGK previously audited Old Ayala's 2022/2021 financials.

item 4.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 1.0

Ayala Pharmaceuticals, Inc. dismissed Marcum LLP as its auditor.

Action: dismissal
Auditor: Marcum LLP

Exact text from the filing

1, 2022 and 2021 were audited by Marcum LLP (“Marcum”). After the completion of the Merger, the audit committee of the Registrant’s board of directors (the “Audit Committee”), which has the responsibility to engage and dismiss the Registrant’s auditor under Rule 10A-3(b)(2), made the decision to continue the engagement of both KFGK and Marcum, KFGK to serve as the independent registered public accounting firm to audit the consolidated financial statements of Old Ayala (the accounting acquiror in the Merger) for the year ended December 31, 2022 and Marcum to serve as the independent registered public accounting firm to audit the consolidated financial statements of Pre-Merger Advaxis (the accounting acquiree in the Merger) for the year ended October 31, 2022. Dismissal of Independent Registered Public Accounting Firm On April 5, 2023, the Audit Committee determined to discontinue the enga

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 1.0

Ayala Pharmaceuticals, Inc. engaged Kost, Forer, Gabbay & Kasierer as its auditor.

Action: engagement
Auditor: Kost, Forer, Gabbay & Kasierer

Exact text from the filing

inancial statements of Old Ayala as of and for the years ended December 31, 2022 and 2021 were audited by Kost, Forer, Gabbay & Kasierer, a Member of EY Global (“KFGK”). The financial statements of Pre-Merger Advaxis as of and for the years ended October 31, 2022 and 2021 were audited by Marcum LLP (“Marcum”). After the completion of the Merger, the audit committee of the Registrant’s board of directors (the “Audit Committee”), which has the responsibility to engage and dismiss the Registrant’s auditor under Rule 10A-3(b)(2), made the decision to continue the engagement of both KFGK and Marcum, KFGK to serve as the independent registered public accounting firm to audit the consolidated financial

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001493152-23-011596

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.